Publicacions en col·laboració amb investigadors/es de Hospital Virgen del Camino (39)

2024

  1. Subspace corrected relevance learning with application in neuroimaging

    Artificial Intelligence in Medicine, Vol. 149

2023

  1. Recomendaciones de consenso para el tratamiento de la prevención de la migraña

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. 246-253

  2. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life

    Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402

  3. [Translated article] Consensus recommendations on the preventive treatment of migraine

    Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. T246-T253

2022

  1. Eslicarbazepine acetate as therapy in hemifacial spasm

    Neurologia

2021

  1. Delta-24-RGD, an oncolytic adenovirus, increases survival and promotes proinflammatory immune landscape remodeling in models of AT/RT and CNS-PNET

    Clinical Cancer Research, Vol. 27, Núm. 6, pp. 1807-1820

  2. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease

    Neurology, Vol. 97, Núm. 14, pp. E1367-E1381

  3. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein

    Acta Neuropathologica Communications, Vol. 9, Núm. 1

2020

  1. Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study

    Journal of Neuro-Oncology, Vol. 148, Núm. 3, pp. 545-554

  2. Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: A prospective cohort study

    BMC Cardiovascular Disorders, Vol. 20, Núm. 1

  3. RNU6-1 in circulating exosomes differentiates GBM from non-neoplastic brain lesions and PCNSL but not from brain metastases

    Neuro-Oncology Advances, Vol. 2, Núm. 1

2019

  1. Amylin as a potential link between type 2 diabetes and alzheimer disease

    Annals of Neurology, Vol. 86, Núm. 4, pp. 539-551

  2. Globular glial tauopathy caused by MAPT P301T mutation: clinical and neuropathological findings

    Journal of Neurology, Vol. 266, Núm. 10, pp. 2396-2405

  3. Parkinson’s disease with mild cognitive impairment: severe cortical thinning antedates dementia

    Brain Imaging and Behavior, Vol. 13, Núm. 1, pp. 180-188

2018

  1. Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies

    Acta Neuropathologica, Vol. 135, Núm. 6, pp. 877-886

  2. The expression of cannabinoid type 1 receptor and 2-arachidonoyl glycerol synthesizing/degrading enzymes is altered in basal ganglia during the active phase of levodopa-induced dyskinesia

    Neurobiology of Disease, Vol. 118, pp. 64-75

2017

  1. Epicardial Adipose Tissue in the General Middle-aged Population and Its Association With Metabolic Syndrome

    Revista Espanola de Cardiologia, Vol. 70, Núm. 4, pp. 254-260

2016

  1. Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment

    Human Brain Mapping, Vol. 37, Núm. 3, pp. 968-977

2015

  1. Factors Associated with Tremor Changes during Sedation with Dexmedetomidine in Parkinson's Disease Surgery

    Stereotactic and Functional Neurosurgery, Vol. 93, Núm. 6, pp. 393-399

  2. The Relationship Between Atrophy and Hypometabolism: Is It Regionally Dependent in Dementias?

    Current Neurology and Neuroscience Reports, Vol. 15, Núm. 7